title: Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancer.
abstract: Metastatic colorectal cancer has a low cure rate. When resection of metastases is feasible, however, survival is increased. We present a case of a patient with metastases that responded well to bevacizumab-containing treatment. Consequently, surgical resection of metastases was possible resulting in increased survival.
authors.affiliation: Faculty of Medicine of Marília, Department of Oncology and Radiotherapy, Faculdade Medicina, Marilia. slafonso@famema.br
authors.forename: Sergio
authors.initials: S
authors.lastname: Afonso
authors.forename: Gustavo
authors.initials: G
authors.lastname: Viani
authors.forename: Vitor
authors.initials: V
authors.lastname: Afonso
authors.forename: Eduardo
authors.initials: E
authors.lastname: Stefano
authors.forename: Sandra
authors.initials: S
authors.lastname: Afonso
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin